- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder, Overactive in Poland
Total 3493 results
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Neurogenic Detrusor OveractivityDenmark, Poland
-
Medical University of LublinCompletedOveractive Bladder | Urinary IncontinencePoland
-
Medical University of LublinCompletedOveractive Bladder | Urinary Incontinence | Stress Urinary Incontinence | Urge IncontinencePoland
-
Astellas Pharma IncCompletedOveractive Bladder | Neurogenic Detrusor OveractivityBelgium, Canada, Denmark, Netherlands, Poland, Turkey, United Kingdom
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedUrinary Incontinence, UrgeUnited States
-
NovartisProcter and GambleCompletedOveractive Bladder (OAB)United States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Belgium, Russian Federation, Czech Republic, Germany, United States
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, Germany, United States, Canada, United Kingdom, Belgium
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Women and Infants Hospital of Rhode IslandUnknownUrinary Incontinence | Urge Incontinence | Overactive Bladder Syndrome | Detrusor Instability | Detrusor HyperreflexiaUnited States
-
PfizerCompletedOveractive Bladder SyndromeUnited States, Canada, Greece, Brazil, Korea, Republic of, Singapore, Poland, India, Norway, Slovakia, Spain, Belgium, Philippines, Netherlands, Sweden, Thailand, Malaysia, Germany, Colombia
-
AllerganCompletedOveractive BladderUnited Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
SunovionPPD; ICON Clinical Research; Covance; Dainippon Sumitomo Pharma America; ClinPhone...CompletedOveractive Bladder Syndrome (OABS)France, United Kingdom, United States, Estonia, Germany, Latvia, Lithuania, Poland, Spain
-
Velicept Therapeutics, Inc.Completed
-
elbion AGTerminatedOveractive Bladder | Urinary IncontinenceSweden, Germany, Poland
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
-
Ono Pharmaceutical Co. LtdCompletedOveractive BladderPoland, Ukraine, Romania, Russian Federation, Czech Republic, Hungary, Netherlands, Sweden, Germany
-
PfizerCompletedOveractive BladderUnited States
-
PfizerCompletedOveractive BladderKorea, Republic of, United States, Denmark, Germany, Canada, Hungary, Poland, France, United Kingdom, Slovakia, Sweden, Mexico, Czech Republic, Finland, Italy, Lithuania, Argentina, Chile, Colombia, Egypt, Greece, Norway, Philippines, Russian Federation and more
-
PfizerCompleted
-
Gnankang Sarah NapoeRecruitingUrinary Incontinence, Urge | Overactive Bladder SyndromeUnited States
-
Watson PharmaceuticalsCompleted
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesUnited States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
-
BayerCompletedOveractive BladderAustria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
-
AllerganTerminatedUrinary Incontinence | Urinary Bladder | OveractiveUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Italy, Netherlands, Norway, Poland, South Africa, United Kingdom
-
PfizerCompletedOveractive BladderCanada, United States, Costa Rica, Hungary, Slovakia, Spain, Colombia, India, Russian Federation, Ireland, Korea, Republic of, Germany, Sweden, Poland, Bulgaria, Estonia, Brazil, Greece, Latvia, Lithuania, Malaysia, Romania, Singapore, South Africa and more
-
PfizerCompletedOveractive BladderCosta Rica, United States, Korea, Republic of, Germany, Slovakia, Ukraine, Belgium, Poland, Czechia
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Belgium, Canada, Russian Federation, United States, Germany, Czechia
-
AllerganCompletedOveractive Bladder | Urinary IncontinencePoland, United Kingdom, Germany, Canada, Belgium, United States, Czechia
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
Astellas Pharma IncCompletedOveractive Bladder | Detrusor OveractivityBelgium, Norway, Spain, Sweden, Italy, Czech Republic, Hungary, France, Canada, Germany, Austria, United Kingdom, Bulgaria, Russian Federation, United States, Poland, Slovakia, Turkey, Israel, Romania
-
Urovant Sciences GmbHCompletedOveractive BladderUnited States, Latvia, Hungary, Canada, Lithuania, Poland
-
University of California, San FranciscoPfizerCompletedOveractive Bladder | Urge Urinary IncontinenceUnited States
-
Targacept Inc.CompletedOveractive BladderUnited States
-
BayerCompletedOveractive Bladder | Detrusor OveractivitySpain, Belgium, Canada, Netherlands, Switzerland, Russian Federation, Germany, Israel, Hungary, Portugal, France, Poland, Czech Republic
-
PfizerCompletedOveractive BladderDenmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
-
Duramed ResearchCompletedOveractive BladderUnited States, Canada
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
GlaxoSmithKlineCompletedOveractive Bladder | Incontinence, Urinary and Urinary Bladder, OveractiveUnited States, Canada
-
Urovant Sciences GmbHCompleted
-
AbbVieCompletedOveractive Detrusor | Neurogenic BladderUnited States
-
Astellas Pharma Europe B.V.CompletedPediatric | Neurogenic Detrusor OveractivityUnited States, Belgium, Korea, Republic of, Philippines, Poland, United Kingdom
-
Duramed ResearchCompletedStudy to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderUrinary IncontinenceUnited States, Canada